# Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

> **NCT00872352** · PHASE3 · UNKNOWN · sponsor: **Wolfson Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Multiple Myeloma
- Peripheral Neuropathy

## Interventions

- **PROCEDURE:** EMG

## Key facts

- **NCT ID:** NCT00872352
- **Lead sponsor:** Wolfson Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-04
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00872352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00872352, "Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00872352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*